DTRA: Novel Mechanism Based Multiple Drug Resistance Broad Spectrum Anti-Threat Bacterial Pathogens Antibiotics – Federal Business Opportunities: Opportunities

See on Scoop.itBiodefense News

The objective of this RFI is to identify candidate Small organic Molecules Inhibitors (SMI) that have the potential to potently and specifically inhibit multiple drug resistance (MDR) bacterial pathogens including tier-1 CDC/DoD listed bacteria.

The DoD is interested in exploring availability of SMIs that possess new mechanism of action(s) and are bactericidal against broad MDR bacterial infectious pathogens. DoD welcomes engagement of all sources that have reached at an advanced Phase I clinical studies or completed this clinical Phase.

See on www.fbo.gov

Leave a Reply